Nasdaq warns IO Biotech (NASDAQ: IOBT) on $50M market value rule

NodeGuardian · 2026-02-15T03:24:39+00:00

IO Biotech Inc. has been notified by Nasdaq of non-compliance regarding the minimum market value requirement. The company has 180 days to rectify this or face potential delisting, with an option to appeal.

NodeGuardian

2026-02-15 03:24:39

Abstract generation in progress

IO Biotech Inc. (NASDAQ: IOBT) has received a notice from Nasdaq stating it is non-compliant with the requirement to maintain a market value of listed securities of at least $50 million for 30 consecutive business days. The company has 180 calendar days, until August 11, 2026, to regain compliance by having its market value at or above $50 million for at least ten consecutive business days. Failure to comply could lead to delisting, though the company would have an opportunity to appeal.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes